HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Herbalife Third Quarter Sales Spurred By 20% Gain In The Americas

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Herbalife International recorded a 12.1% increase in net sales to $238.9 mil. in the third quarter, boosted by a strong performance in the Americas. The Asia/Pacific Rim segment recorded growth in the quarter as well, but Europe was flat. Herbalife plans to begin operating in India Nov. 10, bringing the number of countries in which it sells its products to 45.

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

US Consumer Health Market People News: Herbalife, Seed Health, Electrolit, Atlas Bars, More

US Women’s Health Sector: Hip Hop Stars Invest In Proov, Good Clean Love Names CEO

Reckitt Sees R&D Investment Translate To Volume Growth

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

See All
UsernamePublicRestriction

Register

RS140533

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By